Standard & Poor's Confirms Rating for Gerresheimer



    DUSSELDORF, Germany, May 12 /CNW/ - The rating agency Standard & Poor's
has today confirmed the current rating of BB+ for the Gerresheimer Group and
continues to categorize the outlook as stable. The focus of the MDAX company
on the pharma & life science industry is therefore assessed as positive and
sustainable by the rating agency.

    About Gerresheimer

    Gerresheimer employs around 10,000 people in 42 locations in Europe,
America and Asia. In the financial year 2008, worldwide sales totalled
EUR1.06bn. The product portfolio ranges from pharmaceutical vials made of
glass and plastic through to complex drug-delivery systems for the pharma &
life science industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterized by high
technical and regulatory barriers.





For further information:

For further information: Contact Press: Burkhard Lingenberg, Director
Corporate Communication & Marketing, Phone +49-211-6181-250, Fax
+49-211-6181-241, e-mail b.lingenberg@gerresheimer.com; Contact Investor
Relations: Anke Linnartz, Director Corporate Investor Relations, Phone
+49-211-6181-314, Fax +49-211-6181-121, e-mail a.linnartz@gerresheimer.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890